PARABON COMPUTATION, INC.
Cloud-based software platform (Crush-MDR and Frontier) for analyzing gene-gene interactions in genome-wide association studies using distributed computing.
- Sector
- Biotech
- Total capital
- $2.6M
- Federal grants
- $1.5M
- 2 awards · 2015–2016
- Rank in peer group#10 of 20
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $1.1M
- 3 awards · NASA
- Rank in Biotech#181 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · CG-GRID: Computational Genetics Grid Resource for Interaction Discovery$717K
- Federal grantHealth and Human S · Phase II · CG-GRID: Computational Genetics Grid Resource for Interaction Discovery$743K
- Federal contractNASA · This Contract Is For Computer Software Services. The Contractor Will Adhere To A Documented Iterative And Incremental Software Development Process That, At A Macro Level, First Establishes Core Requirements, Then Develops A Model Of The Desired Behavior, Creates An Architecture, Evolves The Implementation, And Finally Manages Post-delivery Evolution. At A Micro Level, Engineers Practice Object Oriented Design Methodology And Follow An Agile "release Early And Often" Development Cycle. In Cases S$270K
- Federal contractNASA · This SBIR Phase 2 Project Will Produce A Software Service Infrastructure That Enables Most Modeling And Simulation (m&s) Activities From Code Development And Compilation To Runtime Execution And Collaboration To Be Performed From A Standard Web Browser Across Cloud- And Grid-enabled Computing Resources. By Addressing The Security, Scalability And Virtualization Challenges That Have Heretofore Prevented Service-centric M&s From Being Practical, This First-of-its-kind Modeling And Simulation As A $750K
- Federal contractNASA · Componentized Models As A Service (cmaas) This Small Business Innovation Research (SBIR) Phase I Project, Which Will Conclude With A Technical Readiness Level Of 3-4, Will Demonstrate The Feasibility Of The Componentized Models As A Service (cmaas) System, A Web-centric Software Service Architecture That Will Dramatically Improve The Manner In Which Nasa's Modeling Assets Are Developed, Deployed And Used. Under This Service Architecture, Models Will Be Exposed As Web Services That Are Fully Con$99K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 20 peers
Line = medianBiotech · Software
- Federal grants#10 · top 50%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- Htg Molecular Diagnostics, IncSimilar federal contract value in Biotech · $1.2M in contracts
- EXTEND BIOSCIENCES INCSimilar federal contract value in Biotech · $1.1M in contracts
- ORBIS BIOSCIENCES, INC.Similar federal contract value in Biotech · $1.1M in contracts
- ANTIRADICAL THERAPEUTICS LLCSimilar federal contract value in Biotech · $1.1M in contracts
- Zen-Bio, Inc.Similar federal contract value in Biotech · $1.1M in contracts
- SunFire Biotechnologies LLCSimilar federal contract value in Biotech · $1.1M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .